newsfilter
← Latest News
Business Wire·

Elan’s Response to Royalty Pharma Statement of Today

DUBLIN--(BUSINESS WIRE)--The Board of Elan Corporation, plc (NYSE:ELN) (the Company) acknowledges this morning's statement by Royalty Management, LLC (Royalty Pharma). Elan’s position remains as outlined on February 25, 2013: